20 (AIDX) Other Non-Current Assets (2024 - 2026)

20's (AIDX) quarterly Other Non-Current Assets came in at $23057.0 in Q1 2026, little changed on a QoQ basis from $23057.0 in Q4 2025.

20 (AIDX) Other Non-Current Assets (2024 - 2026) Analysis & Trends

20 (AIDX) has 3 years of Other Non-Current Assets data on file, last reported at $23057.0 in Q1 2026.

Quarterly Other Non-Current Assets changed N/A year-over-year to $23057.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $23057.0 (changed N/A YoY) and the FY2025 annual result came in at $23057.0, down 85.76% from the prior year.
Other Non-Current Assets held at $23057.0 in Q1 2026, from $23057.0 in the prior quarter.
In the past five years, Other Non-Current Assets ranged from a high of $161957.0 in Q4 2024 to a low of $23057.0 in Q4 2025.
A 3-year average of $69357.0 and a median of $23057.0 in 2025 frame the typical range for Other Non-Current Assets.
The widest YoY moves for Other Non-Current Assets: up 85.76% in 2025, down 85.76% in 2025.
Tracing AIDX's Other Non-Current Assets over 3 years: stood at $161957.0 in 2024, then sank by 85.76% to $23057.0 in 2025, then changed by 0.0% to $23057.0 in 2026.
The last three Other Non-Current Assets figures came in at $23057.0 (Q1 2026), $23057.0 (Q4 2025), and $161957.0 (Q4 2024), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Other Non-Current Assets (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn	-
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn	3.23 Bn
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn	4.15 Bn
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn	45.22 Bn
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn	616.40 Mn
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn	273.70 Mn
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn	2.25 Bn
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn	148.78 Mn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn	215.10 Mn
10	20	5.55 Mn	1.00 Mn	304,727.00	23,057.00

Download Data